Genetic and environmental prenatal risk factors play a role in early childhood atopic dermatitis (AD), according to a review published online Jan. 27 in the Annals of Dermatology.
Feb 9, 2023
0
0
Lanolin, an emollient and moisturizer, has been called a paradoxical allergen. The potential for lanolin to cause contact allergy in humans has been well documented in the literature, and the phenomenon of lanolin allergenicity ...
Jan 30, 2023
0
6
Bronchial asthma, a chronic inflammatory disease of the airways that is reversible in certain cases, usually presents with cough, difficulty of breathing, and wheezing. Although most people can successfully control asthma ...
Jan 20, 2023
0
27
In February 2022, the American College of Allergy, Asthma and Immunology (ACAAI) convened experts in atopic dermatitis (AD) and food allergy to examine the issue of racial disparities affecting people with these conditions.
Jan 11, 2023
0
6
Elementary school-age children with developmental disorders are more likely to have allergic diseases, according to a study published in the January issue of Pediatrics International.
Jan 10, 2023
0
6
Prenatal exposure to acid-suppressive medications (ASMs) seems not to be associated with allergic diseases in offspring, according to a study published online Jan. 9 in JAMA Pediatrics.
Jan 10, 2023
0
14
Atopic dermatitis (AD) in children is associated with an increased risk for subsequent fracture, according to a research letter published online Nov. 9 in Allergy.
Dec 27, 2022
0
4
A weekly dose of dupilumab, a monoclonal antibody, led to a reduction of symptoms and tissue improvement in young adults and adolescents with eosinophilic esophagitis (EoE), according to a new study published in the New England ...
Dec 22, 2022
0
25
Adults with atopic dermatitis (AD) have a significantly increased risk for new-onset migraine, according to a letter to the editor published online Oct. 21 in the Journal of the European Academy of Dermatology & Venereology.
Dec 16, 2022
0
4
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up ...
Dec 9, 2022
1
70
